## AXON: Axon Enterprise, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -3.5% below STRENGTH zone (4.0-10.0%); PEG 2.86 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (56% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($500.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Can Axon Maintain EBITDA Margin Momentum Amid Cost Pressures?**
- Source: TradingView | 20251202T172110 | Somewhat-Bullish | Relevance: 100%
- Axon Enterprise, Inc. (AXON) demonstrated strong financial performance in the first nine months of 2025, with a significant increase in adjusted EBITDA and margin expansion driven by product sales and cost management. The company is optimistic about its full-year 2025 EBITDA outlook, despite facing challenges in price performance and valuation compared to its peers. While Axon focuses on improving its margins, competitors like Kratos Defense & Security Solutions, Inc. and Teledyne Technologies Incorporated are struggling with cost pressures and declining margins.

**2. Schroder Investment Management Group Purchases 3,914 Shares of Axon Enterprise, Inc $AXON**
- Source: MarketBeat | 20251202T120415 | Somewhat-Bullish | Relevance: 100%
- Schroder Investment Management Group increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.1% in Q2 2025, purchasing 3,914 additional shares to hold a total of 79,985 shares valued at approximately $66.2 million. Other institutional investors also significantly increased their positions, while company insiders, including the CEO and CFO, sold shares during the last quarter. Analysts maintain a "Moderate Buy" consensus rating for Axon, despite the company missing EPS estimates but reporting a 30.6% increase in revenue year-over-year.

**3. New York State Common Retirement Fund Has $31.33 Million Stake in Axon Enterprise, Inc $AXON**
- Source: MarketBeat | 20251202T120415 | Neutral | Relevance: 100%
- The New York State Common Retirement Fund increased its stake in Axon Enterprise by 4.4% to 37,839 shares, valued at $31.33 million as of its most recent SEC filing. Despite missing EPS expectations, Axon Enterprise saw its revenue grow by 30.6%, and analysts largely maintain a "Moderate Buy" consensus with an average target price of $814. Insiders sold a significant number of shares, totaling $26.44 million, yet still own 4.40% of the company's stock.

**4. Axon Enterprise Inc. stock underperforms Monday when compared to competitors**
- Source: MarketWatch | 20251201T165100 | Bearish | Relevance: 100%
- Axon Enterprise Inc. (AXON) stock fell 1.28% to $533.21 on Monday, marking an underperformance compared to the broader market indices. This decline snapped a five-day winning streak for the company's shares. The S&P 500 Index and Dow Jones Industrial Average also experienced declines on the same trading day.

**5. Axon Enterprise CAO Mak sells $39719 in stock**
- Source: Investing.com | 20251203T175000 | Neutral | Relevance: 100%
- Axon Enterprise Chief Accounting Officer Jennifer H. Mak sold 74 shares of company stock for $39,719 on December 3, 2025, and an additional 85 shares for $45,911 on December 1, 2025, to cover tax obligations. These transactions were executed under a Rule 10b5-1 trading plan. Despite a stock price decline, Axon reported 32% revenue growth and maintains a strong financial position with more cash than debt.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | RBC Capital | $860 | $0 | 0% |
| 2025-11-06 | Barclays | $702 | $861 | -18% |
| 2025-11-05 | UBS | $610 | $840 | -27% |
| 2025-11-05 | Goldman Sachs | $800 | $940 | -15% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | RBC Capital | init | Outperform |
| 2025-11-06 | Barclays | main | Overweight |
| 2025-11-05 | UBS | main | Neutral |
| 2025-11-05 | Goldman Sachs | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.00M) |
| Sells | 19 ($26.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+4.2%)
- Blackrock Inc.: 10.4% (+8.3%)
- State Street Corpora: 4.3% (+6.4%)
- FMR, LLC: 3.8% (+2.1%)
- Geode Capital Manage: 2.8% (+5.7%)

### Key Risks

1. Heavy insider selling: $26M sold (19 transactions in 90 days).
2. Valuation risk: PEG 2.9x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 19.7% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.86 signals overvaluation risk, limited margin of safety. Forward P/E 72.1x stretched relative to 19% growth. Balance sheet: strong liquidity (3.1x). Revenue growth strong at 25% YoY. Analyst sentiment negative (4 target cuts vs 0 raises). Insider selling cluster ($26.0M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.4B |
| Beta | 1.40 |
| 52W Range | $469.24 - $885.92 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.86 |
| Forward P/E | 72.1 |
| Current P/E | 86.1 |
| YoY Growth | 19.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -10.1% to -3.5% (+6.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.6%) - potential reversal signal. Underperforming sector by 3.0pp, stock-specific weakness. Below SMA200 (0.80x), long-term trend not supportive. MACD histogram positive (5.09), confirming momentum. Volume at 56% of 20MA suggests lack of conviction. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.49% (CS: 19) | Weak |
| RSI_14 | 34.3 | Neutral |
| MACD Histogram | 5.09 | Bullish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 0.838x | Below |
| vs SMA200 | 0.803x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $543.55
- **Stop Loss:** $500.01 (8.0% risk)
- **Target:** $587.09 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 21
- **Position Value:** $11,414.55
- **Portfolio %:** 11.41%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-24 (Est: $1.60)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.54 | $1.17 | -24.1% |
| 2025Q2 | $1.46 | $2.12 | +45.0% |
| 2025Q1 | $1.28 | $1.41 | +10.2% |
| 2024Q4 | $1.40 | $2.08 | +48.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*